"Ephrin-B2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A transmembrane domain containing ephrin that binds with high affinity to EPHB1 RECEPTOR; EPHB3 RECEPTOR; and EPHB4 RECEPTOR. Expression of ephrin-B2 occurs in a variety of adult tissues. During embryogenesis, high levels of ephrin-B2 is seen in the PROSENCEPHALON; RHOMBENCEPHALON; developing SOMITES; LIMB BUD; and bronchial arches.
Descriptor ID |
D036388
|
MeSH Number(s) |
D12.644.276.500.700 D12.776.467.500.700 D12.776.543.287.700 D23.529.500.700
|
Concept/Terms |
Ephrin-B2- Ephrin-B2
- Ephrin B2
- LERK-5 Gene Product
- LERK 5 Gene Product
- Efbn2 Gene Product
- Eplg5 Gene Product
- LERK-5 Protein
- LERK 5 Protein
- Eplg5 Protein
Eph Ligand Family 2 Protein, Mammalian- Eph Ligand Family 2 Protein, Mammalian
- Htk Ligand
- Ligand, Htk
- Mammalian ELF-2
- ELF-2, Mammalian
- Mammalian ELF 2
- HTKL Protein
- ELF-2 Protein, Mammalian
- ELF 2 Protein, Mammalian
- Mammalian ELF-2 Protein
|
Below are MeSH descriptors whose meaning is more general than "Ephrin-B2".
Below are MeSH descriptors whose meaning is more specific than "Ephrin-B2".
This graph shows the total number of publications written about "Ephrin-B2" by people in this website by year, and whether "Ephrin-B2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 0 | 1 | 1 |
2005 | 0 | 1 | 1 |
2011 | 0 | 1 | 1 |
2012 | 1 | 0 | 1 |
2014 | 0 | 1 | 1 |
2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ephrin-B2" by people in Profiles.
-
Kemmerling N, Wunderlich P, Theil S, Linnartz-Gerlach B, Hersch N, Hoffmann B, Heneka MT, de Strooper B, Neumann H, Walter J. Intramembranous processing by ?-secretase regulates reverse signaling of ephrin-B2 in migration of microglia. Glia. 2017 07; 65(7):1103-1118.
-
Carroll KJ, Esain V, Garnaas MK, Cortes M, Dovey MC, Nissim S, Frechette GM, Liu SY, Kwan W, Cutting CC, Harris JM, Gorelick DA, Halpern ME, Lawson ND, Goessling W, North TE. Estrogen defines the dorsal-ventral limit of VEGF regulation to specify the location of the hemogenic endothelial niche. Dev Cell. 2014 May 27; 29(4):437-53.
-
Aguilar HC, Iorio RM. Henipavirus membrane fusion and viral entry. Curr Top Microbiol Immunol. 2012; 359:79-94.
-
Mirza AM, Aguilar HC, Zhu Q, Mahon PJ, Rota PA, Lee B, Iorio RM. Triggering of the newcastle disease virus fusion protein by a chimeric attachment protein that binds to Nipah virus receptors. J Biol Chem. 2011 May 20; 286(20):17851-60.
-
Carlson TR, Yan Y, Wu X, Lam MT, Tang GL, Beverly LJ, Messina LM, Capobianco AJ, Werb Z, Wang R. Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice. Proc Natl Acad Sci U S A. 2005 Jul 12; 102(28):9884-9.
-
Lawson ND, Scheer N, Pham VN, Kim CH, Chitnis AB, Campos-Ortega JA, Weinstein BM. Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development. 2001 Oct; 128(19):3675-83.